全文获取类型
收费全文 | 1319篇 |
免费 | 112篇 |
国内免费 | 69篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 65篇 |
妇产科学 | 23篇 |
基础医学 | 221篇 |
口腔科学 | 7篇 |
临床医学 | 180篇 |
内科学 | 283篇 |
皮肤病学 | 10篇 |
神经病学 | 52篇 |
特种医学 | 74篇 |
外科学 | 112篇 |
综合类 | 21篇 |
预防医学 | 110篇 |
眼科学 | 39篇 |
药学 | 175篇 |
中国医学 | 1篇 |
肿瘤学 | 123篇 |
出版年
2022年 | 6篇 |
2021年 | 34篇 |
2020年 | 15篇 |
2019年 | 26篇 |
2018年 | 27篇 |
2017年 | 21篇 |
2016年 | 22篇 |
2015年 | 26篇 |
2014年 | 40篇 |
2013年 | 59篇 |
2012年 | 59篇 |
2011年 | 60篇 |
2010年 | 29篇 |
2009年 | 38篇 |
2008年 | 47篇 |
2007年 | 91篇 |
2006年 | 54篇 |
2005年 | 66篇 |
2004年 | 39篇 |
2003年 | 45篇 |
2002年 | 37篇 |
2001年 | 40篇 |
2000年 | 45篇 |
1999年 | 52篇 |
1998年 | 33篇 |
1997年 | 24篇 |
1996年 | 25篇 |
1995年 | 22篇 |
1994年 | 13篇 |
1993年 | 13篇 |
1992年 | 20篇 |
1991年 | 29篇 |
1990年 | 32篇 |
1989年 | 34篇 |
1988年 | 40篇 |
1987年 | 32篇 |
1986年 | 25篇 |
1985年 | 26篇 |
1984年 | 19篇 |
1983年 | 12篇 |
1982年 | 8篇 |
1980年 | 7篇 |
1979年 | 11篇 |
1978年 | 8篇 |
1977年 | 9篇 |
1976年 | 7篇 |
1974年 | 5篇 |
1973年 | 6篇 |
1972年 | 9篇 |
1971年 | 10篇 |
排序方式: 共有1500条查询结果,搜索用时 31 毫秒
61.
Dan J. Stein Sergio Aguilar-Gaxiola Jordi Alonso Ronny Bruffaerts Peter de Jonge Zharoui Liu Jose Miguel Caldas-de-Almeida Siobhan O’Neill Maria Carmen Viana Ali Obaid Al-Hamzawi Mattias C. Angermeyer Corina Benjet Ron de Graaf Finola Ferry Viviane Kovess-Masfety Daphna Levinson Giovanni de Girolamo Silvia Florescu Chiyi Hu Norito Kawakami Josep Maria Haro Marina Piazza Jose Posada-Villa Bogdan J. Wojtyniak Miguel Xavier Carmen C.W. Lim Ronald C. Kessler Kate M. Scott 《General hospital psychiatry》2014
62.
63.
Raden Indra Tresnanda Sawkar Vijay Pramod Ferry Safriadi 《Asian Pacific journal of cancer prevention》2021,22(10):3101
Objective:This systematic review aimed to determine the efficacy of ketoconazole in the treatment of metastatic castration-resistant prostate cancer (mCRPC). Materials and Methods:A literature search was performed on four databases of PubMed, Google Scholar, Cochrane Database of Systematic Reviews, and Directory of Open Access Journals (DOAJ). The initial search resulted in 602 articles, which were progressively eliminated based on duplication, irrelevancy, and unsuitable methodology. A total of seventeen articles were included in the final analysis, including four randomized controlled trials, nine retrospective cohorts, and four prospective cohorts, with a total population of 1,095 patients. A 200-400 mg, tid dose of ketoconazole was used in these studies along with corticoid replacement therapy with hydrocortisone, 20-30 mg in the morning and 10-20 mg in the evening, or prednisone, 5 mg, bid. Results:Based on our findings, 8 out of 17 studies reported PSA decrease of >50% in approximately half of the population, with a more significant PSA response at 400 mg ketoconazole dosage, and the average progression-free survival (PFS) of 2.6-14.5 months, or time to progression of 3.2-6.7 months. Conclusion:Ketoconazole with corticosteroid could be an effective alternative for the treatment of mCRPC with a satisfactory PSA response and disease progression.Key Words: Ketoconazole, Corticosteroid, mCRPC, PSA, PFS, Response 相似文献
64.
65.
66.
Enos Tangke Arung Irawan Wijaya Kusuma Sri Purwatiningsih Seong-Soo Roh Chae Ha Yang Soohyeon Jeon Yong-Ung Kim Edi Sukaton Joko Susilo Yuli Astuti Britanto Dani Wicaksono Ferry Sandra Kuniyoshi Shimizu Ryuichiro Kondo 《Journal of acupuncture and meridian studies》2009,2(4):306-308
We investigated the leaves of Kleinhovia hospita, a plant which has been traditionally used in Indonesia as phytotherapy to cure liver disease, to describe antioxidant materials from plant sources. K. hospita leaves were extracted with methanol and further partitioned into n-hexane, diethyl ether, and ethyl acetate. The antioxidant activity of each fraction and the residue was assessed using a 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging method and their cytotoxicity on HepG2 liver cancer cells was determined by a MTT assay. The K. hospita leaf methanol extract showed strong antioxidant activity (96%) compared with vitamin C (98%) by the DPPH method and the measured activity from the subsequent extracts of the methanol extract were 48.9% for n-hexane, 74.0% for diethyl ether, 84.3% for ethyl acetate, and 77.1% for the residue. The MTT assay showed the cytotoxicity of the methanol extract on HepG2 cells at 14%, 76%, and 80% at concentrations of 50μg/mL, 87.5μg/mL, and 125μg/mL, respectively. Leaf extracts of the medicinal plant K. hospita showed potent antioxidant activity and moderate cytotoxicity on HepG2 liver cancer cells. 相似文献
67.
68.
四种中成药对气血双虚模型小鼠血象及免疫水平的影响 总被引:1,自引:0,他引:1
目的:为艾滋病抗病毒疗法所致的骨髓不良反应筛选疗效确切的中成药,观察分析参芪颗粒、复方阿胶浆、贞芪扶正颗粒、复方皂矾丸四种中成药对放血和注射环磷酰胺联合复制的气血双虚模型小鼠血象及免疫水平的影响。方法:实验于2005-08/09在河南中医学院药理实验室完成。①参芪颗粒(江西山高制药有限公司生产,批号040702);复方阿胶浆(山东东阿阿胶股份有限公司生产,批号050446);贞芪扶正颗粒(甘肃扶正药业科技股份有限公司生产,批号040803);复方皂矾丸(陕西郝其军制药有限责任公司生产,批号041014);当归补血口服液(郑州市协和制药厂生产,批号041122);环磷酰胺(上海华联制药有限公司生产,批号050101)。②选取清洁级昆明种小鼠150只,随机数字表法分为15组,10只/组:1~3组分别灌服参芪颗粒混悬液3,2,1g/kg;4~6组分别灌服复方阿胶浆30,20,10mL/kg;7~9组分别灌服贞芪扶正颗粒混悬液15,10,5g/kg;10~12组分别灌服复方皂矾丸混悬液2.4,1.6,0.8g/kg;第13组灌服当归补血口服液10g/kg;剩余2组为空白对照组和模型对照组,分别给于同体积生理盐水10g/kg。各组给药1次/d,连续给药10d。③除空白对照组外,其他各组从给药第1天开始建立气血双虚模型。每只鼠尾部放血0.25mL/10g,然后分别于第2,4,6,8天腹腔注射环磷酰胺80,40,40,40mg/kg。空白对照组同时间点仅腹腔注射等体积生理盐水。末次注射环磷酰胺后2h,眼眶取血,一部分用于血象测定,另一部分离心取血清,测定血细胞比容及血清中巨噬细胞集落刺激因子水平;解剖取胸腺和脾脏,检测胸腺皮质厚度、胸腺淋巴细胞数、脾小结大小、脾脏淋巴细胞数病理学指标的变化。结果:150只小鼠全部进入结果分析,放血和注射环磷酰胺并用可成功建立小鼠气血双虚模型。①与模型对照组比较,参芪颗粒3g/kg组、贞芪扶正颗粒10,5g/kg组、复方皂矾丸1.6g/kg组均可升高气血双虚模型小鼠白细胞水平(t=2.18~2.74,P<0.05),贞芪扶正颗粒15g/kg组作用更为显著(t=2.98,P<0.01);参芪颗粒1g/kg组、复方阿胶浆20mL/kg组、贞芪扶正颗粒15,10g/kg组均可升高红细胞水平(t=2.44~2.69,P<0.05),复方阿胶浆30mL/kg组、贞芪扶正颗粒5g/kg组、复方皂矾丸2.4,1.6g/kg组作用更为显著(t=2.91~3.66,P<0.01);当归补血口服液组、复方阿胶浆20mL/kg组、参芪颗粒3,1g/kg组、贞芪扶正颗粒15,10,5g/kg组均可升高血红蛋白水平(t=2.27~2.85,P<0.05),复方阿胶浆30mL/kg组、复方皂矾丸2.4,1.6g/kg组作用更为显著(t=3.07~4.04,P<0.01);当归补血口服液组、参芪颗粒3,2g/kg组均可升高血小板水平(t=2.20~2.41,P<0.05)。②与模型对照组比较,参芪颗粒2g/kg组、贞芪扶正颗粒5g/kg组均可升高气血双虚模型小鼠血细胞比容(t=2.01~2.62,P<0.05),参芪颗粒1g/kg组、复方阿胶浆30,20,10mL/kg组、贞芪扶正颗粒15,10,5g/kg组、复方皂矾丸2.4,1.6,0.8g/kg组作用更为显著(t=3.18~4.36,P<0.01);参芪颗粒2g/kg组、复方阿胶浆30,20,10mL/kg组、贞芪扶正颗粒15,10,5g/kg组、复方皂矾丸2.4,1.6g/kg组均可显著升高巨噬细胞集落刺激因子水平(t=3.60~6.80,P<0.01)。③与模型对照组比较,当归补血口服液组、参芪颗粒3,2,1g/kg组、复方阿胶浆30,20,10mL/kg组、贞芪扶正颗粒15,10,5g/kg组、复方皂矾丸2.4,1.6,0.8g/kg组均可显著增加气血双虚模型小鼠胸腺皮质厚度(t=3.71~9.34,P<0.01),增大脾小结(t=3.36~11.97,P<0.01),增加脾脏淋巴细胞数(t=4.29~10.44,P<0.01);复方阿胶浆30mL/kg组可明显增加小鼠胸腺淋巴细胞数(t=2.45,P<0.05),当归补血口服液组、参芪颗粒3,2,1g/kg组、复方阿胶浆20,10mL/kg组、贞芪扶正颗粒15,10,5g/kg组、复方皂矾丸2.4g/kg组作用更为显著(t=3.22~8.20,P<0.01)。结论:①四种中成药对气血双虚模型小鼠血红蛋白升高作用相近,以复方阿胶浆和贞芪扶正颗粒对白细胞和红细胞水平升高作用为强,以复方阿胶浆和贞芪扶正颗粒对血小板水平升高作用为优。②四种中成药对气血双虚模型小鼠血细胞比容的影响无差异,以贞芪扶正颗粒和复方皂矾丸对巨噬细胞集落刺激因子水平的升高作用为优。③以参芪颗粒、复方阿胶浆、贞芪扶正颗粒对胸腺皮质厚度和淋巴细胞数的促进作用为优,以参芪颗粒、贞芪扶正颗粒、复方皂矾丸对脾小结和脾脏淋巴细胞数的促进作用为优。 相似文献
69.
Belinda S. Cowling Thierry Chevremont Ivana Prokic Christine Kretz Arnaud Ferry Catherine Coirault Olga Koutsopoulos Vincent Laugel Norma B. Romero Jocelyn Laporte 《The Journal of clinical investigation》2014,124(3):1350-1363
Centronuclear myopathies (CNM) are congenital disorders associated with muscle weakness and abnormally located nuclei in skeletal muscle. An autosomal dominant form of CNM results from mutations in the gene encoding dynamin 2 (DNM2), and loss-of-function mutations in the gene encoding myotubularin (MTM1) result in X-linked CNM (XLCNM, also called myotubular myopathy), which promotes severe neonatal hypotonia and early death. Currently, no effective treatments exist for XLCNM. Here, we found increased DNM2 levels in XLCNM patients and a mouse model of XLCNM (Mtm1–/y). Generation of Mtm1–/y mice that were heterozygous for Dnm2 revealed that reduction of DNM2 in XLCNM mice restored life span, whole-body strength, and diaphragm function and increased muscle strength. Additionally, classic CNM-associated histological features, including fiber atrophy and nuclei mispositioning, were absent or reduced. Ultrastructural analysis revealed improvement of sarcomere organization and triad structures. Skeletal muscle–specific decrease of Dnm2 during embryogenesis or in young mice after disease onset revealed that the rescue associated with downregulation of Dnm2 is cell autonomous and is able to stop and potentially revert XLCNM progression. These data indicate that MTM1 and DNM2 regulate muscle organization and force through a common pathway. Furthermore, despite DNM2 being a key mechanoenzyme, its reduction is beneficial for XLCNM and represents a potential therapeutic approach for patients. 相似文献
70.
Marlies H Craig Brian L Sharp Musawenkosi LH Mabaso Immo Kleinschmidt 《International journal of health geographics》2007,6(1):44